Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteries

Arteriosclerosis, Thrombosis, and Vascular Biology
M RomanoE Hurt-Camejo

Abstract

We recently reported on the immunolocalization of type II secretory nonpancreatic phospholipase A2 (snpPLA2) in human atherosclerotic lesions. In the present study, we present data on the distribution and ultrastructural localization of snpPLA2 in adjacent nonatherosclerotic and atherosclerotic regions of human arteries. Electron microscopy (EM) of immunogold labeling techniques with a monoclonal antibody was used to analyze arterial tissue. The human specimens analyzed were obtained from autopsy and surgery cases. The results with EM showed a stronger snpPLA2 immunoreactivity in regions of arteries with atherosclerotic lesions than in regions without lesions from the same individual. snpPLA2 immunoreactivity was stronger in the arterial intima of atherosclerotic than of nonatherosclerotic tissue. EM-immunogold examination revealed that the majority of snpPLA2 was localized along the extracellular matrix, associated with collagen fibers and other extracellular matrix structures. Intracellular snpPLA2 was observed in electron-dense vesicles in intimal cells. snpPLA2 was also found in contact with large, extracellular lipid droplets. These results support the hypothesis that extracellular snpPLA2 is localized at sites where it ma...Continue Reading

References

Oct 1, 1992·Free Radical Biology & Medicine·H EsterbauerG Jürgens
Nov 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·A DaughertyG Schonfeld
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M T QuinnD Steinberg
Nov 1, 1985·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J R GuytonT A Schifani
Mar 17, 1995·Biochemical and Biophysical Research Communications·M D RosenthalR C Franson
Jan 1, 1994·Methods in Molecular Biology·C Oliver
Jun 2, 1995·The Journal of Biological Chemistry·W H Moolenaar
Feb 10, 1995·The Journal of Biological Chemistry·E SchönherrH Kresse
Jun 15, 1994·The Biochemical Journal·S P ChockA B Mukherjee
Feb 1, 1994·Annals of Surgery·A A SantosC A Dinarello
Jan 1, 1994·Prostaglandins, Leukotrienes, and Essential Fatty Acids·A M Evangelou
Apr 14, 1994·Biochimica Et Biophysica Acta·J H Exton
Apr 1, 1994·European Journal of Biochemistry·R Dua, W Cho
Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·T NakanoR Ross
Aug 1, 1993·The Journal of Clinical Investigation·H F McMurrayD Steinberg
Jan 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·Y AsaokaK Inoue
Aug 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C N SerhanC C Leslie
Sep 1, 1996·Journal of Cardiovascular Pharmacology·J E FreemanN A Flavahan
Dec 13, 1996·The Journal of Biological Chemistry·I T WeberR V Iozzo
Mar 21, 1997·The Journal of Biological Chemistry·M O PentikäinenP T Kovanen
Jul 11, 1997·Atherosclerosis·E Hurt-Camejo, G Camejo

❮ Previous
Next ❯

Citations

Oct 3, 2009·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Markus van der GietUwe J F Tietge
Mar 30, 2011·Analytical and Bioanalytical Chemistry·Kei YamamotoMakoto Murakami
Jan 16, 2008·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Minna HelinHannu Uusitalo
Dec 21, 2000·Current Atherosclerosis Reports·G CamejoG Bondjers
May 14, 2003·Cellular Signalling·Sajal Chakraborti
Nov 30, 2000·Trends in Cardiovascular Medicine·P Sartipy, E Hurt-Camejo
Apr 13, 2000·Journal of Internal Medicine·M O PentikäinenP T Kovanen
Nov 13, 1998·Current Opinion in Lipidology·K J Williams, I Tabas
Oct 26, 2000·Current Opinion in Lipidology·E Hurt-CamejoP Sartipy
Feb 19, 2009·BMC Cardiovascular Disorders·Jose O LeiteMaria Luz Fernandez
Aug 12, 2004·Biological & Pharmaceutical Bulletin·Makoto Murakami, Ichiro Kudo
Jun 19, 2012·Cellular & Molecular Biology Letters·Shigeki KamitaniKohji Hanasaki
Jan 1, 2012·ISRN Inflammation·M S AhmedQing H Meng
Sep 24, 2004·The Journal of Membrane Biology·H A Wilson-AshworthJ D Bell
Mar 15, 2008·European Journal of Clinical Investigation·R NijmeijerH W M Niessen
Sep 26, 2015·Apoptosis : an International Journal on Programmed Cell Death·Anil AhsanZeyao Tang
Nov 13, 1998·Current Opinion in Lipidology·J L Witztum, J A Berliner
May 23, 2015·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·W PruzanskiA Kuksis
Sep 23, 2003·Current Opinion in Lipidology·Makoto Murakami, Ichiro Kudo
May 15, 2001·Laboratory Investigation; a Journal of Technical Methods and Pathology·W PruzanskiA Kuksis
Sep 7, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Karina Cristina GiannottiCatarina Teixeira
Nov 18, 2000·Biochimica Et Biophysica Acta·M AndreaniG Béréziat
Nov 4, 2004·Biochimica Et Biophysica Acta·Seiko MasudaIchiro Kudo
Oct 31, 2006·Biochimica Et Biophysica Acta·Birgitta RosengrenEva Hurt-Camejo
Feb 25, 2009·Archives of Medical Research·Li Wei-huaLin Kai-min

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.